BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 34284174)

  • 1. Expression characteristics of interferon-stimulated genes and possible regulatory mechanisms in lupus patients using transcriptomics analyses.
    Deng Y; Zheng Y; Li D; Hong Q; Zhang M; Li Q; Fu B; Wu L; Wang X; Shen W; Zhang Y; Chang J; Song K; Liu X; Shang S; Cai G; Chen X
    EBioMedicine; 2021 Aug; 70():103477. PubMed ID: 34284174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Cyclin-Dependent Kinase 1 as a Novel Regulator of Type I Interferon Signaling in Systemic Lupus Erythematosus.
    Wu L; Qin Y; Xia S; Dai M; Han X; Wu Y; Zhang X; Ma J; Wang Y; Tang Y; Liu Z; Zhu W; Jallal B; Yao Y; Qu B; Shen N
    Arthritis Rheumatol; 2016 May; 68(5):1222-32. PubMed ID: 26663909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice.
    Chen K; Deng Y; Shang S; Tang L; Li Q; Bai X; Chen X
    Biomed Pharmacother; 2022 Sep; 153():113433. PubMed ID: 36076550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
    Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
    J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key interferon-stimulated genes for indicating the condition of patients with systemic lupus erythematosus.
    Shen M; Duan C; Xie C; Wang H; Li Z; Li B; Wang T
    Front Immunol; 2022; 13():962393. PubMed ID: 35967341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I interferon-regulated gene expression and signaling in murine mixed glial cells lacking signal transducers and activators of transcription 1 or 2 or interferon regulatory factor 9.
    Li W; Hofer MJ; Songkhunawej P; Jung SR; Hancock D; Denyer G; Campbell IL
    J Biol Chem; 2017 Apr; 292(14):5845-5859. PubMed ID: 28213522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocytic myeloid-derived suppressor cells contribute to IFN-I signaling activation of B cells and disease progression through the lncRNA NEAT1-BAFF axis in systemic lupus erythematosus.
    Dong G; Yang Y; Li X; Yao X; Zhu Y; Zhang H; Wang H; Ma Q; Zhang J; Shi H; Ning Z; Yan F; Zhai W; Dai J; Li Z; Li C; Ming J; Xue Q; Meng X; Si C; Xiong H
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165554. PubMed ID: 31513833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Th17-Associated Interstitial Kidney Inflammation in Lupus-Prone Mice Lacking the Gene Encoding STAT-1.
    Yiu G; Rasmussen TK; Ajami B; Haddon DJ; Chu AD; Tangsombatvisit S; Haynes WA; Diep V; Steinman L; Faix J; Utz PJ
    Arthritis Rheumatol; 2016 May; 68(5):1233-44. PubMed ID: 26636548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLE.
    Smith S; Fernando T; Wu PW; Seo J; Ní Gabhann J; Piskareva O; McCarthy E; Howard D; O'Connell P; Conway R; Gallagher P; Molloy E; Stallings RL; Kearns G; Forbess L; Ishimori M; Venuturupalli S; Wallace D; Weisman M; Jefferies CA
    J Autoimmun; 2017 May; 79():105-111. PubMed ID: 28318807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
    Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S
    Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unphosphorylated ISGF3 drives constitutive expression of interferon-stimulated genes to protect against viral infections.
    Wang W; Yin Y; Xu L; Su J; Huang F; Wang Y; Boor PPC; Chen K; Wang W; Cao W; Zhou X; Liu P; van der Laan LJW; Kwekkeboom J; Peppelenbosch MP; Pan Q
    Sci Signal; 2017 Apr; 10(476):. PubMed ID: 28442624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Arsenic Trioxide on INF-gamma Gene Expression in MRL/lpr Mice and Human Lupus.
    Hu H; Chen E; Li Y; Zhu X; Zhang T; Zhu X
    Biol Trace Elem Res; 2018 Aug; 184(2):391-397. PubMed ID: 29159556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib and M351-0056 enhance the function of VISTA and ameliorate the development of SLE via IFN-I and noncanonical NF-κB pathway.
    Yang L; Zhang T; Wang P; Chen W; Liu W; He X; Zhang Y; Jin S; Luo Z; Zhang Z; Wang X; Liu J
    Cell Biol Toxicol; 2023 Dec; 39(6):3287-3304. PubMed ID: 37804401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice.
    Wu L; Jiang X; Qi C; Zhang C; Qu B; Shen N
    Front Immunol; 2021; 12():653989. PubMed ID: 33868295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of gene expression profiles of peripheral blood cells in systemic lupus erythematosus.
    Bae SC; Lee YH
    Cell Mol Biol (Noisy-le-grand); 2018 Jul; 64(10):40-49. PubMed ID: 30084812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptomic, epigenetic, and functional analyses implicate neutrophil diversity in the pathogenesis of systemic lupus erythematosus.
    Mistry P; Nakabo S; O'Neil L; Goel RR; Jiang K; Carmona-Rivera C; Gupta S; Chan DW; Carlucci PM; Wang X; Naz F; Manna Z; Dey A; Mehta NN; Hasni S; Dell'Orso S; Gutierrez-Cruz G; Sun HW; Kaplan MJ
    Proc Natl Acad Sci U S A; 2019 Dec; 116(50):25222-25228. PubMed ID: 31754025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular Inflammation and Dysfunction in Lupus-Prone Mice-IL-6 as Mediator of Disease Initiation.
    Marczynski P; Meineck M; Xia N; Li H; Kraus D; Roth W; Möckel T; Boedecker S; Schwarting A; Weinmann-Menke J
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cluster of highly expressed interferon-stimulated genes associate more with African ancestry than disease activity in patients with systemic lupus erythematosus. A systematic review of cross-sectional studies.
    Siddiqi KZ; Wilhelm TR; Ulff-Møller CJ; Jacobsen S
    Transl Res; 2021 Dec; 238():63-75. PubMed ID: 34343626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping systemic lupus erythematosus heterogeneity at the single-cell level.
    Nehar-Belaid D; Hong S; Marches R; Chen G; Bolisetty M; Baisch J; Walters L; Punaro M; Rossi RJ; Chung CH; Huynh RP; Singh P; Flynn WF; Tabanor-Gayle JA; Kuchipudi N; Mejias A; Collet MA; Lucido AL; Palucka K; Robson P; Lakshminarayanan S; Ramilo O; Wright T; Pascual V; Banchereau JF
    Nat Immunol; 2020 Sep; 21(9):1094-1106. PubMed ID: 32747814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.